ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Oct 4, 2019
PepsiCo Posts Solid Quarterly Report, Targets Powerful Long-Term Growth Trends
On October 3, PepsiCo reported third quarter earnings for fiscal 2019 (12 week period ended September 7) that were positively received by the market as the beverage and snack company beat both consensus top and bottom line estimates. PepsiCo still has its eyes on the ball in the face of exogenous shocks (i.e. the US-China trade war and the potential for an EU-US trade war) as management targets secular growth trends in emerging and developing markets, but we still think the company’s valuation is stretched after its impressive year-to-date rally. Shares of PEP yield ~2.7% as of this writing.
Oct 2, 2019
Zimmer Biomet’s Near-Term Outlook Is Less Rosy Than Management Would Have You Believe
Shares of Zimmer Biomet are trading on lofty expectations and investors may be in for a shock should Zimmer Biomet continue to underperform during the second half of 2019. Foreign currency headwinds continue to grow as seen through the strength of the US Dollar Index during the third quarter of 2019. We like Zimmer Biomet’s deleveraging activities but think its share price has gotten ahead of itself given these rising headwinds, lack of top line growth, and deteriorating net operating cash flows. We are staying away from Zimmer Biomet.
Oct 1, 2019
Carvana Seeks to Disrupt an Enormous Market
Image Source: Carvana Co. – IR Presentation. Carvana seeks to disrupt the used car and used light truck market in the United States as a leading e-commerce platform for used automobile sales. Perhaps best known for its “car vending machines” that are located in key metropolitan areas across the US, Carvana wants to fundamentally transform the way consumers buy, sell, and ultimately ascertain the proper value for used automobiles. Unlike more recent IPOs of high flying companies with absolutely no chance of becoming profitable, Carvana appears to have a scalable business model. For the established companies in this arena, we caution that Carvana may one day represent a serious competitive threat.
Sep 30, 2019
Economic Commentary: US-Listed Chinese Names, 60-40 Stock-Bond Allocation and More
Image shown for informational/illustration purposes only.  There’s an interesting saying that I came across recently...that hits at the most important component of any fiduciary approach: capital preservation. The saying was “Friends don’t let friends buy and hold.” We’ve always employed the Valuentum strategy, which we believe is much more promising that a traditional buy and hold strategy. – Brian Nelson, CFA
Sep 26, 2019
Nike Posts a Solid Quarter and Issues Strong Guidance
Image Shown: Shares of Nike Inc pop on September 25 after reporting a strong first quarter for fiscal 2020 and issuing favorable guidance for the full fiscal year.Nike reported earnings for the first quarter of its fiscal 2020 (ended August 31) on September 24 and investors clearly liked what they saw. The firm has been performing quite well given foreign currency headwinds and the ongoing US-China trade war, and it’s clear that hasn’t undermined core demand for its popular sportswear and equipment products. We are still staying on the sidelines given how shares of NKE are richly valued, in our view.
Sep 25, 2019
Best Ideas Newsletter Portfolio Holding PayPal Can Thrive in a Post-eBay World
Image Source: PayPal Holdings Inc -- IR Presentation. We continue to like Best Ideas Newsletter portfolio holding PayPal Holdings as a way to gain exposure to the very attractive payment processing and financial technology industry, complementing our top-weighted Visa holding. PayPal can do more than just survive in a post-eBay world, it can thrive.
Sep 24, 2019
The Orthodontics Industry Is Getting Disrupted
Image Source: SmileDirectClub Inc - S-1 SEC Filing. SmileDirectClub, the teledentistry startup that makes 3D-printed clear aligners which are a cheaper alternative to braces (albeit with drawbacks when compared to the traditional braces route), went public this September at $23/share. While SmileDirectClub’s growth trajectory is quite intriguing, we prefer to wait until we get a better idea of the regulatory landscape the start-up faces and what its financial performance will look like now that it’s a public entity in the limelight. For Align, we are staying firmly away from the company as competitive pressures will continue to mount going forward. Neither company pays out a common dividend at this time.
Sep 23, 2019
Empirical Support for Porter’s “Gospel,” Plus Comments on the “Head Fake” Rotation
“Let’s be very clear: There is strong empirical quantitative evidence that the price-to-fair value equation (“factor”) is predictive of returns, which is what matters for value investors, and in Morningstar’s case, the moat assessment is just part of that overarching conclusion (fair value estimate). Researchers continue to attack the moat “factor” on grounds that don’t make any sense, in my view, and are cherry-picking parameters to assess value investing.” – Brian Nelson, CFA
Sep 22, 2019
Jim Chanos Attacks DaVita and Throws Shade at Warren Buffett
DaVita is a midsized kidney dialysis company with strong free cash flows. However, the company is coming under fire from famed short seller Jim Chanos who recently threw shade at Warren Buffett. Image Source: DaVita Inc – IR Presentation.
Sep 20, 2019
Dividend Increases/Decreases for the Week Ending September 20
Let's take a look at companies that raised/lowered their dividend this week.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.